nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Feeling abnormal—Ibandronate—osteoporosis	0.00097	0.00097	CcSEcCtD
Tobramycin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000967	0.000967	CcSEcCtD
Tobramycin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000963	0.000963	CcSEcCtD
Tobramycin—Myalgia—Pamidronate—osteoporosis	0.000962	0.000962	CcSEcCtD
Tobramycin—Back pain—Conjugated Estrogens—osteoporosis	0.000962	0.000962	CcSEcCtD
Tobramycin—Urticaria—Alendronate—osteoporosis	0.000961	0.000961	CcSEcCtD
Tobramycin—Epistaxis—Estradiol—osteoporosis	0.00096	0.00096	CcSEcCtD
Tobramycin—Ill-defined disorder—Zoledronate—osteoporosis	0.000958	0.000958	CcSEcCtD
Tobramycin—Abdominal pain—Alendronate—osteoporosis	0.000956	0.000956	CcSEcCtD
Tobramycin—Body temperature increased—Alendronate—osteoporosis	0.000956	0.000956	CcSEcCtD
Tobramycin—Sinusitis—Estradiol—osteoporosis	0.000955	0.000955	CcSEcCtD
Tobramycin—Anaemia—Zoledronate—osteoporosis	0.000954	0.000954	CcSEcCtD
Tobramycin—Nervous system disorder—Risedronate—osteoporosis	0.000952	0.000952	CcSEcCtD
Tobramycin—Discomfort—Pamidronate—osteoporosis	0.000951	0.000951	CcSEcCtD
Tobramycin—Angioedema—Zoledronate—osteoporosis	0.000943	0.000943	CcSEcCtD
Tobramycin—Skin disorder—Risedronate—osteoporosis	0.000943	0.000943	CcSEcCtD
Tobramycin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000943	0.000943	CcSEcCtD
Tobramycin—Abdominal pain—Raloxifene—osteoporosis	0.00094	0.00094	CcSEcCtD
Tobramycin—Body temperature increased—Raloxifene—osteoporosis	0.00094	0.00094	CcSEcCtD
Tobramycin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000937	0.000937	CcSEcCtD
Tobramycin—Urticaria—Ibandronate—osteoporosis	0.000935	0.000935	CcSEcCtD
Tobramycin—Malaise—Zoledronate—osteoporosis	0.000931	0.000931	CcSEcCtD
Tobramycin—Body temperature increased—Ibandronate—osteoporosis	0.000931	0.000931	CcSEcCtD
Tobramycin—Abdominal pain—Ibandronate—osteoporosis	0.000931	0.000931	CcSEcCtD
Tobramycin—Confusional state—Pamidronate—osteoporosis	0.00093	0.00093	CcSEcCtD
Tobramycin—Vertigo—Zoledronate—osteoporosis	0.000928	0.000928	CcSEcCtD
Tobramycin—Leukopenia—Zoledronate—osteoporosis	0.000924	0.000924	CcSEcCtD
Tobramycin—Anaphylactic shock—Pamidronate—osteoporosis	0.000922	0.000922	CcSEcCtD
Tobramycin—Rhinitis—Estradiol—osteoporosis	0.000916	0.000916	CcSEcCtD
Tobramycin—Urticaria—Calcitriol—osteoporosis	0.000916	0.000916	CcSEcCtD
Tobramycin—Abdominal pain—Calcitriol—osteoporosis	0.000911	0.000911	CcSEcCtD
Tobramycin—Body temperature increased—Calcitriol—osteoporosis	0.000911	0.000911	CcSEcCtD
Tobramycin—Angioedema—Conjugated Estrogens—osteoporosis	0.000908	0.000908	CcSEcCtD
Tobramycin—Pharyngitis—Estradiol—osteoporosis	0.000907	0.000907	CcSEcCtD
Tobramycin—Hypersensitivity—Estropipate—osteoporosis	0.000905	0.000905	CcSEcCtD
Tobramycin—Nervous system disorder—Pamidronate—osteoporosis	0.000905	0.000905	CcSEcCtD
Tobramycin—Thrombocytopenia—Pamidronate—osteoporosis	0.000903	0.000903	CcSEcCtD
Tobramycin—Urinary tract disorder—Estradiol—osteoporosis	0.000903	0.000903	CcSEcCtD
Tobramycin—Vomiting—Etidronic acid—osteoporosis	0.000902	0.000902	CcSEcCtD
Tobramycin—Cough—Zoledronate—osteoporosis	0.000901	0.000901	CcSEcCtD
Tobramycin—Connective tissue disorder—Estradiol—osteoporosis	0.000898	0.000898	CcSEcCtD
Tobramycin—Urethral disorder—Estradiol—osteoporosis	0.000896	0.000896	CcSEcCtD
Tobramycin—Rash—Etidronic acid—osteoporosis	0.000895	0.000895	CcSEcCtD
Tobramycin—Dermatitis—Etidronic acid—osteoporosis	0.000894	0.000894	CcSEcCtD
Tobramycin—Vertigo—Conjugated Estrogens—osteoporosis	0.000893	0.000893	CcSEcCtD
Tobramycin—Hypersensitivity—Alendronate—osteoporosis	0.000891	0.000891	CcSEcCtD
Tobramycin—Headache—Etidronic acid—osteoporosis	0.000889	0.000889	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000884	0.000884	CcSEcCtD
Tobramycin—Asthenia—Estropipate—osteoporosis	0.000881	0.000881	CcSEcCtD
Tobramycin—Visual impairment—Estradiol—osteoporosis	0.000881	0.000881	CcSEcCtD
Tobramycin—Anorexia—Pamidronate—osteoporosis	0.000879	0.000879	CcSEcCtD
Tobramycin—Chest pain—Zoledronate—osteoporosis	0.000879	0.000879	CcSEcCtD
Tobramycin—Myalgia—Zoledronate—osteoporosis	0.000879	0.000879	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000873	0.000873	CcSEcCtD
Tobramycin—Paraesthesia—Risedronate—osteoporosis	0.000871	0.000871	CcSEcCtD
Tobramycin—Pruritus—Estropipate—osteoporosis	0.000869	0.000869	CcSEcCtD
Tobramycin—Discomfort—Zoledronate—osteoporosis	0.000868	0.000868	CcSEcCtD
Tobramycin—Asthenia—Alendronate—osteoporosis	0.000868	0.000868	CcSEcCtD
Tobramycin—Hypersensitivity—Ibandronate—osteoporosis	0.000868	0.000868	CcSEcCtD
Tobramycin—Cough—Conjugated Estrogens—osteoporosis	0.000868	0.000868	CcSEcCtD
Tobramycin—Dyspnoea—Risedronate—osteoporosis	0.000865	0.000865	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000859	0.000859	CcSEcCtD
Tobramycin—Pruritus—Alendronate—osteoporosis	0.000856	0.000856	CcSEcCtD
Tobramycin—Eye disorder—Estradiol—osteoporosis	0.000854	0.000854	CcSEcCtD
Tobramycin—Tinnitus—Estradiol—osteoporosis	0.000852	0.000852	CcSEcCtD
Tobramycin—Confusional state—Zoledronate—osteoporosis	0.00085	0.00085	CcSEcCtD
Tobramycin—Hypersensitivity—Calcitriol—osteoporosis	0.000849	0.000849	CcSEcCtD
Tobramycin—Myalgia—Conjugated Estrogens—osteoporosis	0.000846	0.000846	CcSEcCtD
Tobramycin—Chest pain—Conjugated Estrogens—osteoporosis	0.000846	0.000846	CcSEcCtD
Tobramycin—Asthenia—Ibandronate—osteoporosis	0.000845	0.000845	CcSEcCtD
Tobramycin—Nausea—Etidronic acid—osteoporosis	0.000843	0.000843	CcSEcCtD
Tobramycin—Anaphylactic shock—Zoledronate—osteoporosis	0.000843	0.000843	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000841	0.000841	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00084	0.00084	CcSEcCtD
Tobramycin—Diarrhoea—Estropipate—osteoporosis	0.00084	0.00084	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000838	0.000838	CcSEcCtD
Tobramycin—Pruritus—Ibandronate—osteoporosis	0.000833	0.000833	CcSEcCtD
Tobramycin—Pain—Risedronate—osteoporosis	0.00083	0.00083	CcSEcCtD
Tobramycin—Angiopathy—Estradiol—osteoporosis	0.000829	0.000829	CcSEcCtD
Tobramycin—Paraesthesia—Pamidronate—osteoporosis	0.000828	0.000828	CcSEcCtD
Tobramycin—Diarrhoea—Alendronate—osteoporosis	0.000827	0.000827	CcSEcCtD
Tobramycin—Asthenia—Calcitriol—osteoporosis	0.000827	0.000827	CcSEcCtD
Tobramycin—Nervous system disorder—Zoledronate—osteoporosis	0.000826	0.000826	CcSEcCtD
Tobramycin—Immune system disorder—Estradiol—osteoporosis	0.000826	0.000826	CcSEcCtD
Tobramycin—Thrombocytopenia—Zoledronate—osteoporosis	0.000825	0.000825	CcSEcCtD
Tobramycin—Mediastinal disorder—Estradiol—osteoporosis	0.000824	0.000824	CcSEcCtD
Tobramycin—Dyspnoea—Pamidronate—osteoporosis	0.000822	0.000822	CcSEcCtD
Tobramycin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00082	0.00082	CcSEcCtD
Tobramycin—Skin disorder—Zoledronate—osteoporosis	0.000818	0.000818	CcSEcCtD
Tobramycin—Pruritus—Calcitriol—osteoporosis	0.000816	0.000816	CcSEcCtD
Tobramycin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000814	0.000814	CcSEcCtD
Tobramycin—Diarrhoea—Raloxifene—osteoporosis	0.000814	0.000814	CcSEcCtD
Tobramycin—Dizziness—Estropipate—osteoporosis	0.000812	0.000812	CcSEcCtD
Tobramycin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000811	0.000811	CcSEcCtD
Tobramycin—Diarrhoea—Ibandronate—osteoporosis	0.000806	0.000806	CcSEcCtD
Tobramycin—Anorexia—Zoledronate—osteoporosis	0.000803	0.000803	CcSEcCtD
Tobramycin—Decreased appetite—Pamidronate—osteoporosis	0.000802	0.000802	CcSEcCtD
Tobramycin—Dizziness—Alendronate—osteoporosis	0.0008	0.0008	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Erythema—Estradiol—osteoporosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Gastrointestinal pain—Risedronate—osteoporosis	0.000794	0.000794	CcSEcCtD
Tobramycin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000791	0.000791	CcSEcCtD
Tobramycin—Pain—Pamidronate—osteoporosis	0.000789	0.000789	CcSEcCtD
Tobramycin—Diarrhoea—Calcitriol—osteoporosis	0.000789	0.000789	CcSEcCtD
Tobramycin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000788	0.000788	CcSEcCtD
Tobramycin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000787	0.000787	CcSEcCtD
Tobramycin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000787	0.000787	CcSEcCtD
Tobramycin—Dizziness—Raloxifene—osteoporosis	0.000787	0.000787	CcSEcCtD
Tobramycin—Vomiting—Estropipate—osteoporosis	0.000781	0.000781	CcSEcCtD
Tobramycin—Dysgeusia—Estradiol—osteoporosis	0.000779	0.000779	CcSEcCtD
Tobramycin—Dizziness—Ibandronate—osteoporosis	0.000779	0.000779	CcSEcCtD
Tobramycin—Rash—Estropipate—osteoporosis	0.000774	0.000774	CcSEcCtD
Tobramycin—Dermatitis—Estropipate—osteoporosis	0.000774	0.000774	CcSEcCtD
Tobramycin—Anorexia—Conjugated Estrogens—osteoporosis	0.000773	0.000773	CcSEcCtD
Tobramycin—Urticaria—Risedronate—osteoporosis	0.000771	0.000771	CcSEcCtD
Tobramycin—Back pain—Estradiol—osteoporosis	0.00077	0.00077	CcSEcCtD
Tobramycin—Headache—Estropipate—osteoporosis	0.000769	0.000769	CcSEcCtD
Tobramycin—Vomiting—Alendronate—osteoporosis	0.000769	0.000769	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000768	0.000768	CcSEcCtD
Tobramycin—Body temperature increased—Risedronate—osteoporosis	0.000767	0.000767	CcSEcCtD
Tobramycin—Abdominal pain—Risedronate—osteoporosis	0.000767	0.000767	CcSEcCtD
Tobramycin—Rash—Alendronate—osteoporosis	0.000763	0.000763	CcSEcCtD
Tobramycin—Dermatitis—Alendronate—osteoporosis	0.000762	0.000762	CcSEcCtD
Tobramycin—Feeling abnormal—Pamidronate—osteoporosis	0.00076	0.00076	CcSEcCtD
Tobramycin—Headache—Alendronate—osteoporosis	0.000758	0.000758	CcSEcCtD
Tobramycin—Paraesthesia—Zoledronate—osteoporosis	0.000757	0.000757	CcSEcCtD
Tobramycin—Vomiting—Raloxifene—osteoporosis	0.000756	0.000756	CcSEcCtD
Tobramycin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000754	0.000754	CcSEcCtD
Tobramycin—Dyspnoea—Zoledronate—osteoporosis	0.000751	0.000751	CcSEcCtD
Tobramycin—Rash—Raloxifene—osteoporosis	0.00075	0.00075	CcSEcCtD
Tobramycin—Dermatitis—Raloxifene—osteoporosis	0.000749	0.000749	CcSEcCtD
Tobramycin—Vomiting—Ibandronate—osteoporosis	0.000749	0.000749	CcSEcCtD
Tobramycin—Headache—Raloxifene—osteoporosis	0.000745	0.000745	CcSEcCtD
Tobramycin—Rash—Ibandronate—osteoporosis	0.000742	0.000742	CcSEcCtD
Tobramycin—Dermatitis—Ibandronate—osteoporosis	0.000742	0.000742	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000739	0.000739	CcSEcCtD
Tobramycin—Ill-defined disorder—Estradiol—osteoporosis	0.000738	0.000738	CcSEcCtD
Tobramycin—Headache—Ibandronate—osteoporosis	0.000738	0.000738	CcSEcCtD
Tobramycin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000733	0.000733	CcSEcCtD
Tobramycin—Vomiting—Calcitriol—osteoporosis	0.000733	0.000733	CcSEcCtD
Tobramycin—Decreased appetite—Zoledronate—osteoporosis	0.000732	0.000732	CcSEcCtD
Tobramycin—Nausea—Estropipate—osteoporosis	0.000729	0.000729	CcSEcCtD
Tobramycin—Abdominal pain—Pamidronate—osteoporosis	0.000729	0.000729	CcSEcCtD
Tobramycin—Body temperature increased—Pamidronate—osteoporosis	0.000729	0.000729	CcSEcCtD
Tobramycin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000729	0.000729	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000727	0.000727	CcSEcCtD
Tobramycin—Angioedema—Estradiol—osteoporosis	0.000727	0.000727	CcSEcCtD
Tobramycin—Rash—Calcitriol—osteoporosis	0.000727	0.000727	CcSEcCtD
Tobramycin—Dermatitis—Calcitriol—osteoporosis	0.000726	0.000726	CcSEcCtD
Tobramycin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000723	0.000723	CcSEcCtD
Tobramycin—Headache—Calcitriol—osteoporosis	0.000722	0.000722	CcSEcCtD
Tobramycin—Pain—Zoledronate—osteoporosis	0.000721	0.000721	CcSEcCtD
Tobramycin—Nausea—Alendronate—osteoporosis	0.000718	0.000718	CcSEcCtD
Tobramycin—Malaise—Estradiol—osteoporosis	0.000718	0.000718	CcSEcCtD
Tobramycin—Hypersensitivity—Risedronate—osteoporosis	0.000715	0.000715	CcSEcCtD
Tobramycin—Vertigo—Estradiol—osteoporosis	0.000715	0.000715	CcSEcCtD
Tobramycin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000714	0.000714	CcSEcCtD
Tobramycin—Nausea—Raloxifene—osteoporosis	0.000707	0.000707	CcSEcCtD
Tobramycin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000705	0.000705	CcSEcCtD
Tobramycin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000704	0.000704	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0007	0.0007	CcSEcCtD
Tobramycin—Nausea—Ibandronate—osteoporosis	0.000699	0.000699	CcSEcCtD
Tobramycin—Asthenia—Risedronate—osteoporosis	0.000696	0.000696	CcSEcCtD
Tobramycin—Feeling abnormal—Zoledronate—osteoporosis	0.000694	0.000694	CcSEcCtD
Tobramycin—Cough—Estradiol—osteoporosis	0.000694	0.000694	CcSEcCtD
Tobramycin—Pain—Conjugated Estrogens—osteoporosis	0.000694	0.000694	CcSEcCtD
Tobramycin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000689	0.000689	CcSEcCtD
Tobramycin—Pruritus—Risedronate—osteoporosis	0.000687	0.000687	CcSEcCtD
Tobramycin—Nausea—Calcitriol—osteoporosis	0.000685	0.000685	CcSEcCtD
Tobramycin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000681	0.000681	CcSEcCtD
Tobramycin—Hypersensitivity—Pamidronate—osteoporosis	0.00068	0.00068	CcSEcCtD
Tobramycin—Myalgia—Estradiol—osteoporosis	0.000677	0.000677	CcSEcCtD
Tobramycin—Chest pain—Estradiol—osteoporosis	0.000677	0.000677	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000673	0.000673	CcSEcCtD
Tobramycin—Urticaria—Zoledronate—osteoporosis	0.000669	0.000669	CcSEcCtD
Tobramycin—Discomfort—Estradiol—osteoporosis	0.000669	0.000669	CcSEcCtD
Tobramycin—Body temperature increased—Zoledronate—osteoporosis	0.000666	0.000666	CcSEcCtD
Tobramycin—Abdominal pain—Zoledronate—osteoporosis	0.000666	0.000666	CcSEcCtD
Tobramycin—Diarrhoea—Risedronate—osteoporosis	0.000664	0.000664	CcSEcCtD
Tobramycin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000663	0.000663	CcSEcCtD
Tobramycin—Asthenia—Pamidronate—osteoporosis	0.000662	0.000662	CcSEcCtD
Tobramycin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000658	0.000658	CcSEcCtD
Tobramycin—Confusional state—Estradiol—osteoporosis	0.000655	0.000655	CcSEcCtD
Tobramycin—Pruritus—Pamidronate—osteoporosis	0.000653	0.000653	CcSEcCtD
Tobramycin—Anaphylactic shock—Estradiol—osteoporosis	0.000649	0.000649	CcSEcCtD
Tobramycin—Urticaria—Conjugated Estrogens—osteoporosis	0.000645	0.000645	CcSEcCtD
Tobramycin—Dizziness—Risedronate—osteoporosis	0.000642	0.000642	CcSEcCtD
Tobramycin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000641	0.000641	CcSEcCtD
Tobramycin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000641	0.000641	CcSEcCtD
Tobramycin—Nervous system disorder—Estradiol—osteoporosis	0.000637	0.000637	CcSEcCtD
Tobramycin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000633	0.000633	CcSEcCtD
Tobramycin—Diarrhoea—Pamidronate—osteoporosis	0.000631	0.000631	CcSEcCtD
Tobramycin—Skin disorder—Estradiol—osteoporosis	0.000631	0.000631	CcSEcCtD
Tobramycin—Rash—Ethinyl Estradiol—osteoporosis	0.000628	0.000628	CcSEcCtD
Tobramycin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000627	0.000627	CcSEcCtD
Tobramycin—Headache—Ethinyl Estradiol—osteoporosis	0.000624	0.000624	CcSEcCtD
Tobramycin—Hypersensitivity—Zoledronate—osteoporosis	0.000621	0.000621	CcSEcCtD
Tobramycin—Vomiting—Risedronate—osteoporosis	0.000617	0.000617	CcSEcCtD
Tobramycin—Rash—Risedronate—osteoporosis	0.000612	0.000612	CcSEcCtD
Tobramycin—Dermatitis—Risedronate—osteoporosis	0.000611	0.000611	CcSEcCtD
Tobramycin—Dizziness—Pamidronate—osteoporosis	0.00061	0.00061	CcSEcCtD
Tobramycin—Headache—Risedronate—osteoporosis	0.000608	0.000608	CcSEcCtD
Tobramycin—Asthenia—Zoledronate—osteoporosis	0.000605	0.000605	CcSEcCtD
Tobramycin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000598	0.000598	CcSEcCtD
Tobramycin—Pruritus—Zoledronate—osteoporosis	0.000596	0.000596	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000592	0.000592	CcSEcCtD
Tobramycin—Nausea—Ethinyl Estradiol—osteoporosis	0.000591	0.000591	CcSEcCtD
Tobramycin—Vomiting—Pamidronate—osteoporosis	0.000587	0.000587	CcSEcCtD
Tobramycin—Paraesthesia—Estradiol—osteoporosis	0.000583	0.000583	CcSEcCtD
Tobramycin—Asthenia—Conjugated Estrogens—osteoporosis	0.000582	0.000582	CcSEcCtD
Tobramycin—Rash—Pamidronate—osteoporosis	0.000582	0.000582	CcSEcCtD
Tobramycin—Dermatitis—Pamidronate—osteoporosis	0.000581	0.000581	CcSEcCtD
Tobramycin—Dyspnoea—Estradiol—osteoporosis	0.000579	0.000579	CcSEcCtD
Tobramycin—Headache—Pamidronate—osteoporosis	0.000578	0.000578	CcSEcCtD
Tobramycin—Diarrhoea—Zoledronate—osteoporosis	0.000577	0.000577	CcSEcCtD
Tobramycin—Nausea—Risedronate—osteoporosis	0.000576	0.000576	CcSEcCtD
Tobramycin—Pruritus—Conjugated Estrogens—osteoporosis	0.000574	0.000574	CcSEcCtD
Tobramycin—Decreased appetite—Estradiol—osteoporosis	0.000564	0.000564	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000561	0.000561	CcSEcCtD
Tobramycin—Dizziness—Zoledronate—osteoporosis	0.000557	0.000557	CcSEcCtD
Tobramycin—Pain—Estradiol—osteoporosis	0.000555	0.000555	CcSEcCtD
Tobramycin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000555	0.000555	CcSEcCtD
Tobramycin—Nausea—Pamidronate—osteoporosis	0.000548	0.000548	CcSEcCtD
Tobramycin—Dizziness—Conjugated Estrogens—osteoporosis	0.000537	0.000537	CcSEcCtD
Tobramycin—Vomiting—Zoledronate—osteoporosis	0.000536	0.000536	CcSEcCtD
Tobramycin—Feeling abnormal—Estradiol—osteoporosis	0.000535	0.000535	CcSEcCtD
Tobramycin—Rash—Zoledronate—osteoporosis	0.000531	0.000531	CcSEcCtD
Tobramycin—Gastrointestinal pain—Estradiol—osteoporosis	0.000531	0.000531	CcSEcCtD
Tobramycin—Dermatitis—Zoledronate—osteoporosis	0.000531	0.000531	CcSEcCtD
Tobramycin—Headache—Zoledronate—osteoporosis	0.000528	0.000528	CcSEcCtD
Tobramycin—Vomiting—Conjugated Estrogens—osteoporosis	0.000516	0.000516	CcSEcCtD
Tobramycin—Urticaria—Estradiol—osteoporosis	0.000516	0.000516	CcSEcCtD
Tobramycin—Abdominal pain—Estradiol—osteoporosis	0.000513	0.000513	CcSEcCtD
Tobramycin—Body temperature increased—Estradiol—osteoporosis	0.000513	0.000513	CcSEcCtD
Tobramycin—Rash—Conjugated Estrogens—osteoporosis	0.000512	0.000512	CcSEcCtD
Tobramycin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000511	0.000511	CcSEcCtD
Tobramycin—Headache—Conjugated Estrogens—osteoporosis	0.000508	0.000508	CcSEcCtD
Tobramycin—Nausea—Zoledronate—osteoporosis	0.000501	0.000501	CcSEcCtD
Tobramycin—Nausea—Conjugated Estrogens—osteoporosis	0.000482	0.000482	CcSEcCtD
Tobramycin—Hypersensitivity—Estradiol—osteoporosis	0.000478	0.000478	CcSEcCtD
Tobramycin—Asthenia—Estradiol—osteoporosis	0.000466	0.000466	CcSEcCtD
Tobramycin—Pruritus—Estradiol—osteoporosis	0.000459	0.000459	CcSEcCtD
Tobramycin—Diarrhoea—Estradiol—osteoporosis	0.000444	0.000444	CcSEcCtD
Tobramycin—Dizziness—Estradiol—osteoporosis	0.000429	0.000429	CcSEcCtD
Tobramycin—Vomiting—Estradiol—osteoporosis	0.000413	0.000413	CcSEcCtD
Tobramycin—Rash—Estradiol—osteoporosis	0.000409	0.000409	CcSEcCtD
Tobramycin—Dermatitis—Estradiol—osteoporosis	0.000409	0.000409	CcSEcCtD
Tobramycin—Headache—Estradiol—osteoporosis	0.000407	0.000407	CcSEcCtD
Tobramycin—Nausea—Estradiol—osteoporosis	0.000386	0.000386	CcSEcCtD
